Andrew John Partridge - EVP & Chief Commercial Officer at Turning Point Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Chief Commercial Officer
Stock Symbol
TPTX
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew John Partridge since 7/4/2023

Holdings reported by Andrew John Partridge for Turning Point Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 38,361 $2.92 M $76.00 Feb 9, 2022 Direct
Stock Option (right to buy) 58,600 Feb 9, 2022 Direct Common Stock

Transactions reported by Andrew John Partridge for Turning Point Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership